Insights from a rare myeloproliferative neoplasm with coexisting BCR‐ABL1 fusion gene, CALR, and TET2 mutations treated with nilotinib and ruxolitinib
- Resource Type
- article
- Source
- Clinical Case Reports, Vol 11, Iss 1, Pp n/a-n/a (2023)
- Subject
BCR‐ABL1 fusion gene CALR mutation myeloproliferative neoplasms nilotinib ruxolitinib Medicine Medicine (General) R5-920 - Language
- English
- ISSN
- 2050-0904